由神经生长因子诱导的交感内置促进胃癌恶性转变
Takefumi Itami1, Yukinori Kurokawa2, Takaomi Hagi1
1Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Scientific reports
|January 30, 2025
概括
胃癌中的交感神经促进瘤生长,减少存活率. 准神经生长因子 (NGF) 和上腺素信号可能为这种疾病提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 交感神经存在于瘤组织中,可以促进癌症恶性.
- 神经生长因子 (NGF) 在神经发育和癌症进展中起作用.
研究的目的:
- 在胃癌中量化交感神经密度 (SND).
- 调查SND,NGF表达和患者预后之间的关系.
- 探索NGF和诺亚上腺素在胃癌细胞恶性转变中的作用.
主要方法:
- 免疫组织化学用于量化人类胃癌样本中的SND和NGF表达.
- 在实验室中进行了PC12细胞和胃癌细胞的共同培养实验.
- 使用NGF淘汰和诺拉丁上腺素治疗来评估它们对癌细胞的影响.
主要成果:
- 胃瘤中高SND与患者存活时间显著缩短相关.
- 高NGF表达与SND增加和预后较差有关.
- NGF促进了交感神经元样细胞的延长,而诺拉丁上腺素诱导了恶性转变,增加了侵入性,并增强了胃癌细胞的迁移.
结论:
- 高NGF的胃癌可能会增强交感内置,通过诺亚上腺素信号传递促进恶性转变.
- 准交感神经延长或激活是胃癌的潜在治疗策略.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer
47.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.7K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


